Company Overview of KaloBios Pharmaceuticals, Inc.
Key Executives for KaloBios Pharmaceuticals, Inc.
|Cameron Durrant M.D., MBA||58 Relationships||Chairman of the Board, Chief Executive Officer, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee||56|
|David L. Tousley M.B.A., CPA||11 Relationships||Interim Chief Financial Officer||60|
|Charles J. Democko||No Relationships||Senior Vice President of Regulatory Affairs and Quality||61|
KaloBios Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Cameron Durrant M.D., MBA||58 Relationships||KaloBios Pharmaceuticals, Inc.||56|
|James W. Larrick M.D., Ph.D.||39 Relationships||KaloBios Pharmaceuticals, Inc.||--|
|Ronald Barliant J.D.||5 Relationships||KaloBios Pharmaceuticals, Inc.||71|
|Timothy Morris||5 Relationships||KaloBios Pharmaceuticals, Inc.||54|
|Dale Chappell M.D.||5 Relationships||Black Horse Capital Advisors LLC||46|
KaloBios Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Timothy Morris||5 Relationships||3 Executives|
|Compensation Committee M.D., MBA||Cameron Durrant||58 Relationships||2 Executives|
|Nominating Committee J.D.||Ronald Barliant||5 Relationships||2 Executives|
|Corporate Governance Committee J.D.||Ronald Barliant||5 Relationships||2 Executives|
|Advisory Board M.D., Ph.D.||James W. Larrick||39 Relationships||1 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.